| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEUROBIOLAGING.2005.02.010 |
| P698 | PubMed publication ID | 15927307 |
| P2093 | author name string | Donna Bozyczko-Coyne | |
| Zhi-Liang Wu | |||
| Mary J Savage | |||
| John R Ciallella | |||
| Teresa M O'Kane | |||
| Dorothy G Flood | |||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 377-386 | |
| P577 | publication date | 2005-05-31 | |
| P1433 | published in | Neurobiology of Aging | Q7002141 |
| P1476 | title | Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease | |
| P478 | volume | 27 |
| Q48749106 | A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer's Disease |
| Q24316080 | A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology |
| Q37902514 | APP physiological and pathophysiological functions: insights from animal models. |
| Q48124090 | Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). |
| Q37108156 | Advances on the understanding of the origins of synaptic pathology in AD. |
| Q36354157 | Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen |
| Q35629399 | Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis |
| Q33708360 | Application of "omics" to prion biomarker discovery |
| Q47356578 | Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity |
| Q34146589 | Characterization of the Interaction of β-Amyloid with Transthyretin Monomers and Tetramers |
| Q34344867 | Concerted perturbation observed in a hub network in Alzheimer's disease |
| Q37718997 | Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing |
| Q33997810 | Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons |
| Q37410917 | Failures to reconsolidate memory in a mouse model of Alzheimer's disease |
| Q34807482 | Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability. |
| Q36466472 | Genetics, transcriptomics, and proteomics of Alzheimer's disease |
| Q36055547 | Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease |
| Q37549786 | Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration |
| Q64969037 | Mechanisms of protein toxicity in neurodegenerative diseases. |
| Q35212537 | Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? |
| Q42870334 | Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice |
| Q61449183 | Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease |
| Q34179881 | Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases |
| Q40161957 | Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells |
| Q43125551 | Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice |
| Q57802947 | PACAP deficiency as a model of aging |
| Q34007685 | Pathophysiology of the blood-brain barrier: animal models and methods |
| Q49165016 | Perspectives in Lipocalin-2: Emerging Biomarker for Medical Diagnosis and Prognosis for Alzheimer's Disease |
| Q91893762 | Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome |
| Q90194886 | Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service |
| Q33654605 | Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease |
| Q91855166 | Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia |
| Q90340275 | Retinol-Binding Protein Interferes with Transthyretin-Mediated β-Amyloid Aggregation Inhibition |
| Q37165271 | Role of PACAP in ischemic neural death. |
| Q90355458 | Sailuotong Capsule Prevents the Cerebral Ischaemia-Induced Neuroinflammation and Impairment of Recognition Memory through Inhibition of LCN2 Expression |
| Q26269904 | Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP |
| Q51480347 | The Expression of Transthyretin and Amyloid-β Protein Precursor is Altered in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients. |
| Q22242668 | The endocannabinoid system in normal and pathological brain ageing |
| Q38552803 | Therapeutic potential of PACAP for neurodegenerative diseases |
| Q36752799 | Transcriptional signatures in Huntington's disease |
| Q50244311 | Transcriptomic Analysis of Drosophila Mushroom Body Neurons Lacking Amyloid-β Precursor-Like Protein Activity |
| Q21202832 | Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease? |
| Q36856132 | Transthyretin as both a sensor and a scavenger of β-amyloid oligomers |
Search more.